Literature DB >> 30240724

Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With Spectral-Domain Optical Coherence Tomography in Normal and Diseased Cornea Eyes.

Ruti Sella1, Linda M Zangwill1, Robert N Weinreb1, Natalie A Afshari2.   

Abstract

PURPOSE: To evaluate the performance of the epithelial thickness mapping (ETM) of the iVue spectral-domain optical coherence tomography (SD-OCT) device (Optovue Inc, Fremont, California, USA) in normal and diseased cornea eyes.
DESIGN: Reliability and validity analysis.
METHODS: Sixty eyes of 60 subjects were recruited for the study, which included normal subjects (n = 12) and patients with corneal diseases (12 patients each: dry eye syndrome [DES], contact lens wear, post-laser refractive surgery, and keratoconus). Three repeated scans were acquired on 3 iVue SD-OCTs with device-designated operators from consented subjects. Each subject was scanned on each device. Repeatability (based on random error of repeated scans) and reproducibility (including the random error and the instrument/operator variability) were assessed based on spatial zones derived from a 6-mm-diameter corneal ETM centered on the pupil and compared between the groups.
RESULTS: Fifty-nine eyes qualified for final analysis. Seventy-one of 598 acquired scans (11.9%) were excluded owing to scan quality concerns. The percentage of disqualified scans was similar across normal (10.7%) and diseased eyes (12.1%). Of 527 qualified scans, 40 (7.6%) scans required manual edits of the segmentation lines. Repeatability and reproducibility results were similar, indicating minimal device/operator variability for both groups. Repeatability and reproducibility were similar in all subgroups of cornea patients, excluding the DES group, for which reproducibility was significantly lower (range 3.2%-5.5% for DES patients and 1.1%-2.9% for normal subjects).
CONCLUSIONS: The iVue SD-OCT provides good corneal ETM repeatability and reproducibility in normal and diseased cornea eyes through all map zones.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30240724     DOI: 10.1016/j.ajo.2018.09.008

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Corneal Epithelial Thickness Mapping in the Diagnosis of Ocular Surface Disorders Involving the Corneal Epithelium: A Comparative Study.

Authors:  Arielle Levy; Cristina Georgeon; Juliette Knoeri; Moïse Tourabaly; Loïc Leveziel; Nacim Bouheraoua; Vincent M Borderie
Journal:  Cornea       Date:  2022-03-30       Impact factor: 3.152

2.  [Corneal epithelial thickness in keratoconus patients compared to healthy controls].

Authors:  Larissa Lahme; Jens Julian Storp; Raphael Diener; Nicole Eter; Uwe Hansen; Martin Dominik Leclaire; Maged Alnawaiseh
Journal:  Ophthalmologie       Date:  2022-04-01

3.  Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.

Authors:  Koray Gumus; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2021-02-08       Impact factor: 5.488

Review 4.  Advanced epithelial mapping for refractive surgery.

Authors:  Pooja Khamar; Kavita Rao; Kareeshma Wadia; Ritika Dalal; Tushar Grover; Francesco Versaci; Krati Gupta
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

5.  Corneal and Epithelial Thickness Mapping: Comparison of Swept-Source- and Spectral-Domain-Optical Coherence Tomography.

Authors:  Cristina Georgeon; Ilanite Marciano; Roxane Cuyaubère; Otman Sandali; Nacim Bouheraoua; Vincent Borderie
Journal:  J Ophthalmol       Date:  2021-10-05       Impact factor: 1.909

6.  Biometric Determinants of Epithelial Thickness Profile Across a Wide Range of Refractive Errors.

Authors:  Onur Ozalp; Eray Atalay
Journal:  Ophthalmol Ther       Date:  2022-03-14

Review 7.  A Review of Imaging Biomarkers of the Ocular Surface.

Authors:  William W Binotti; Betul Bayraktutar; M Cuneyt Ozmen; Stephanie M Cox; Pedram Hamrah
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.